Genomes and Genes
Summary: Dialysis fluid being introduced into and removed from the peritoneal cavity as either a continuous or an intermittent procedure.
Articles from Journal RESEARCH
Articles from Journal RESEARCH1
Publications375 found, 100 shown here
- Global trends in rates of peritoneal dialysisArsh K Jain
Division of Nephrology, University of Western Ontario, London, Canada
J Am Soc Nephrol 23:533-44. 2012Although there is a perception that the use of peritoneal dialysis is declining worldwide, compilations of global data are unavailable to test this hypothesis...
- The pathophysiology of the peritoneal membraneOlivier Devuyst
Division of Nephrology, UCL Medical School, 10 Avenue Hippocrate, B 1200 Brussels, Belgium
J Am Soc Nephrol 21:1077-85. 2010The development of peritoneal dialysis (PD) as a successful therapy has and still depends on experimental models to test and understand critical pieces of pathophysiology...
- Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventionsLuiz S Aroeira
Unidad de Biologia Molecular, Hospital Universitario de la Princesa, C Diego de Leon 62, Madrid, Spain
J Am Soc Nephrol 18:2004-13. 2007b>Peritoneal dialysis (PD) is a form of renal replacement and is based on the use of the peritoneum as a semipermeable membrane across which ultrafiltration and diffusion take place...
- Impact of individual and environmental socioeconomic status on peritoneal dialysis outcomes: a retrospective multicenter cohort studyRong Xu
Renal Division, Department of Medicine, Peking University First Hospital, Institute of Nephrology, Peking University, Key Laboratory of Renal Disease, Ministry of Health, Key Laboratory of Renal Disease, Ministry of Education, Beijing, China
PLoS ONE 7:e50766. 2012We aimed to explore the impacts of individual and environmental socioeconomic status (SES) on the outcome of peritoneal dialysis (PD) in regions with significant SES disparity, through a retrospective multicenter cohort in China.
- Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialysisJwa Kyung Kim
Department of Internal Medicine and Kidney Research Institute, Hallym University College of Medicine, Anyang, Republic of Korea
Atherosclerosis 220:208-14. 2012..We determined the levels of sRAGE and EN-RAGE in peritoneal dialysis (PD) patients and evaluated their relationship with carotid atherosclerosis.
- Fluid status in peritoneal dialysis patients: the European Body Composition Monitoring (EuroBCM) study cohortWim Van Biesen
University Hospital Ghent, Ghent, Belgium
PLoS ONE 6:e17148. 2011Euvolemia is an important adequacy parameter in peritoneal dialysis (PD) patients...
- HGF and BMP-7 ameliorate high glucose-induced epithelial-to-mesenchymal transition of peritoneal mesotheliumMin A Yu
Division of Nephrology, Ewha University School of Medicine, YangChun Ku, Seoul, Korea
J Am Soc Nephrol 20:567-81. 2009Over time, peritoneal dialysis results in functional and structural alterations of the peritoneal membrane, but the underlying mechanisms and whether these changes are reversible are not completely understood...
- Cu/Zn ratios are associated with nutritional status, oxidative stress, inflammation, and immune abnormalities in patients on peritoneal dialysisChih Hung Guo
Institute of Biomedical Nutrition, Hung Kuang University, Taichung 433, Taiwan, ROC
Clin Biochem 44:275-80. 2011We evaluated the relationship of the plasma copper/zinc (Cu/Zn) ratio with nutritional status, inflammation, oxidative stress, and immune function in peritoneal dialysis patients.
- The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysisEdward F Vonesh
Baxter Healthcare Corporation, Applied Statistics Center, Round Lake, Illinois 60073, USA
Kidney Int 66:2389-401. 2004..Trends in available data indicate the relative risk of death with hemodialysis (HD) compared to peritoneal dialysis (PD) varies by time on dialysis and the presence of various risk factors...
- Predictors of loss of residual renal function among new dialysis patientsL M Moist
Department of Medicine, University of Western Ontario, London, Canada
J Am Soc Nephrol 11:556-64. 2000..to determine the predictors of RRF loss in a national random sample of patients initiating hemodialysis and peritoneal dialysis. The study controlled for baseline variables and included major predictors...
- Predictors of the rate of decline of residual renal function in incident dialysis patientsMaarten A M Jansen
Division of Nephrology, Department of Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Kidney Int 62:1046-53. 2002..Few studies have been published on risk factors for loss of RRF in dialysis patients. These studies were either retrospective, performed in a small number of patients, or estimated GFR without a urine collection...
- Peritoneal dialysis-related infections recommendations: 2010 updatePhilip Kam Tao Li
Department of Medicine and Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, Hong Kong
Perit Dial Int 30:393-423. 2010
- Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United StatesAustin G Stack
Division of Renal Diseases and Hypertension, Department of Internal Medicine, University of Texas Health Sciences Center at Houston, Houston, Texas, USA
Kidney Int 64:1071-9. 2003It is hypothesized, but not proven, that peritoneal dialysis might be the optimal treatment for end-stage renal disease (ESRD) patients with established congestive heart failure (CHF) through better volume regulation compared with ..
- Serum creatinine level, a surrogate of muscle mass, predicts mortality in peritoneal dialysis patientsJongha Park
Harold Simmons Center for Kidney Disease Research and Epidemiology, Division of Nephrology and Hypertension, University of California Irvine, School of Medicine, Orange, CA, USA
Nephrol Dial Transplant 28:2146-55. 2013In hemodialysis patients, higher serum creatinine (Cr) concentration represents larger muscle mass and predicts greater survival. However, this association remains uncertain in peritoneal dialysis (PD) patients.
- Assessing the validity of an abdominal CT scoring system in the diagnosis of encapsulating peritoneal sclerosisRuth M Tarzi
Imperial College Kidney and Transplant Institute, Hammersmith Hospital, London, UK
Clin J Am Soc Nephrol 3:1702-10. 2008Encapsulating peritoneal sclerosis (EPS) is a severe peritoneal fibrotic reaction in patients on long-term peritoneal dialysis (PD). The early clinical features may be nonspecific...
- Removal of middle molecules and protein-bound solutes by peritoneal dialysis and relation with uremic symptomsBert Bammens
Department of Medicine, Division of Nephrology and Laboratory of Radiopharmaceutical Chemistry, University Hospital Gasthuisberg, Leuven, Belgium
Kidney Int 64:2238-43. 2003Current guidelines for peritoneal dialysis adequacy are based on kinetics of small water-soluble molecules and do not consider the role of other compounds such as middle molecules and protein-bound solutes...
- Encapsulating peritoneal sclerosis in the new millennium: a national cohort studyMichaela C Brown
Scottish Renal Registry, Royal Infirmary, Glasgow, UK
Clin J Am Soc Nephrol 4:1222-9. 2009The study aim was to establish the incidence and characterize all encapsulating peritoneal sclerosis (EPS) cases in patients treated by peritoneal dialysis (PD).
- Predictors of faster decline of residual renal function in Taiwanese peritoneal dialysis patientsChia Te Liao
Division of Nephrology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
Perit Dial Int 28:S191-5. 2008Loss of residual renal function (RRF) in peritoneal dialysis (PD) patients is a powerful predictor of mortality. The present study was conducted to determine the predictors of faster decline of RRF in PD patients in Taiwan.
- Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patientsL Fried
Renal Section, VA Pittsburgh Healthcare System, and Renal Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Am J Kidney Dis 37:337-42. 2001..The purpose of this study was to examine the usefulness of the CCI as a predictor in incident peritoneal dialysis (PD) patients and to examine whether it was a better predictor than simply the number of comorbid ..
- Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factorLuiz S Aroeira
Servicio de Nefrologia, Hospital Universitario de la Princesa, Madrid, Spain
Am J Kidney Dis 46:938-48. 2005During peritoneal dialysis (PD), the peritoneum is exposed to bioincompatible dialysis fluids that cause epithelial-to-mesenchymal transition of mesothelial cells, fibrosis, and angiogenesis...
- Relations between malnutrition-inflammation-atherosclerosis and volume status. The usefulness of bioimpedance analysis in peritoneal dialysis patientsMeltem Sezis Demirci
Division of Nephrology, Ege University School of Medicine, Izmir, Turkey
Nephrol Dial Transplant 26:1708-16. 2011Chronic fluid overload (FO) is frequently present in peritoneal dialysis (PD) patients and is associated with hypertension and left ventricular hypertrophy and dysfunction, which are important predictors of death in dialysis patients...
- Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damageJesus Loureiro
Unidad de Biología Molecular and Servicio de Nefrología, Hospital Universitario de la Princesa, Instituto de Investigación Sanitaria Princesa IP, Madrid, Spain
J Am Soc Nephrol 22:1682-95. 2011During peritoneal dialysis (PD), mesothelial cells undergo mesothelial-to-mesenchymal transition (MMT), a process associated with peritoneal-membrane dysfunction...
- Recurrent and atypical posterior reversible encephalopathy syndrome in a child with peritoneal dialysisIlknur Girişgen
Department of Pediatrics, Adnan Menderes University Faculty of Medicine, Aydm, Turkey
Turk J Pediatr 52:416-9. 2010..this article, we present recurrent atypical PRES in a hypertensive child with end-stage renal disease on a peritoneal dialysis program as a rare case and we discuss recurrence...
- Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patientsEdwina A Brown
Imperial College Kidney and Transplant Institute, Hammersmith Hospital, London, UK
Nephrol Dial Transplant 25:3755-63. 2010..Little is, however, known about differences in QOL on haemodialysis (HD) and peritoneal dialysis (PD) in older age groups. Randomising patients to either modality to assess outcomes is not feasible.
- Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry dataDavid W Johnson
Australia and New Zealand Dialysis and Transplant Registry, Discipline of Public Health, University of Adelaide, Adelaide, Australia
Nephrol Dial Transplant 24:1598-603. 2009..The aim of the present investigation was to evaluate the rates of hepatitis C virus (HCV) and hepatitis B virus (HBV) infections in peritoneal dialysis (PD) and haemodialysis (HD) patients in the Asia-Pacific region.
- Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patientsIsabel Devolder
Renal Division, University Hospital Ghent, Ghent, Belgium
Perit Dial Int 30:208-14. 2010..A new multifrequency bioimpedance tool has recently been validated. This study compares volume status in peritoneal dialysis (PD) and hemodialysis (HD) patients in a single center.
- Functional effector memory T cells enrich the peritoneal cavity of patients treated with peritoneal dialysisGareth W Roberts
Institute of Nephrology, School of Medicine, Cardiff University, Heath Park, Cardiff, Wales, UK
J Am Soc Nephrol 20:1895-900. 2009..peritonitis adversely affect the structure and function of the peritoneal membrane in patients treated with peritoneal dialysis (PD), but the underlying mechanisms are not well understood...
- The influence of dialysate calcium on progression of arterial stiffness in peritoneal dialysis patientsMeltem Sezis Demirci
Division of Nephrology, Ege University School of Medicine, Izmir, Turkey
Perit Dial Int 29:S15-7. 2009One of the origins of cardiovascular disease in dialysis patients is arterial stiffness. The aim of our study was to assess the relationship between the calcium content of peritoneal dialysis (PD) solution and arterial stiffness.
- Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients?K A Herzig
Department of Renal Medicine, Princess Alexandra Hospital, Ipswich Road, Woolloongabba, Brisbane Q 4102, Australia
J Am Soc Nephrol 12:814-21. 2001..However, its predictive value in peritoneal dialysis (PD) patients has not been assessed...
- Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patientsEric D Weinhandl
Chronic Disease Research Group, Minneapolis, MN 55404, USA
J Am Soc Nephrol 21:499-506. 2010Contemporary comparisons of mortality in matched hemodialysis and peritoneal dialysis patients are lacking...
- Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in VietnamNguyen Hoan Phu
Center for Tropical Diseases, Center for Tropical Diseases, Cho Quan Hospital, Ho Chi Minh City, Vietnam
N Engl J Med 347:895-902. 2002In some parts of the world, peritoneal dialysis is widely used for renal replacement in acute renal failure...
- Associations of serum fetuin-A with malnutrition, inflammation, atherosclerosis and valvular calcification syndrome and outcome in peritoneal dialysis patientsAngela Yee Moon Wang
Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong
Nephrol Dial Transplant 20:1676-85. 2005..However, its relationships with cardiac valvular calcification and atherosclerosis and outcome have not been evaluated in peritoneal dialysis (PD) patients.
- Survival analysis: comparing peritoneal dialysis and hemodialysis in TaiwanChiu Ching Huang
Department of Medicine and Biostatistics Center, China Medical University, Taiwan
Perit Dial Int 28:S15-20. 2008Comparisons of survival in patients on peritoneal dialysis (PD) and on hemodialysis (HD) have been conducted in many Western countries, but publications on this subject in Asian populations are scarce...
- Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysisRajnish Mehrotra
Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor UCLA, Torrance, CA, USA
Am J Kidney Dis 58:418-28. 2011..Whether the threshold level of serum albumin at which mortality risk increases in peritoneal dialysis (PD) patients is the same as for hemodialysis (HD) patients has not been studied.
- Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney diseaseBernard G Jaar
Johns Hopkins University School of Medicine, Johns Hopkins Bloomberg School of Public Health, and Independent Dialysis Foundation, Baltimore, Maryland 21205, USA
Ann Intern Med 143:174-83. 2005..The influence of type of dialysis on survival of patients with end-stage renal disease (ESRD) is controversial...
- Basic mechanisms and clinical implications of peritoneal fibrosisPeter J Margetts
Department of Medicine, McMaster University, Hamilton, Ontario, Canada
Perit Dial Int 23:530-41. 2003..Clinical trials to assess the role of prevention of peritoneal injury using biocompatible solutions and treatments targeted directly at peritoneal fibrosis will be important, but challenging to design and carry out...
- PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damagePilar Sandoval
Unidad de Biologia Molecular, Hospital Universitario de la Princesa, Madrid, Spain
Lab Invest 90:1517-32. 2010Exposure to non-physiological solutions during peritoneal dialysis (PD) produces structural alterations to the peritoneal membrane and ultrafiltration dysfunction...
- Encapsulating peritoneal sclerosis--a clinician's approach to diagnosis and medical treatmentHidetomo Nakamoto
Department of Nephrology, Tokorozawa Kidney Clinic, Tokorozawa, Japan
Perit Dial Int 25:S30-8. 2005Encapsulating peritoneal sclerosis (EPS) is recognized as a serious complication of continuous peritoneal dialysis. A preliminary diagnosis of EPSis usually based on clinical signs and symptoms, which commonly include abdominal pain, ..
- Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003Andrew Davenport
UCL Centre for Nephrology, Royal Free and University College Medical School, London, United Kingdom
Perit Dial Int 29:297-302. 2009Over the past two decades, the rate of peritonitis in patients treated by peritoneal dialysis (PD) has been significantly reduced...
- Age and comorbidity may explain the paradoxical association of an early dialysis start with poor survivalMathilde Lassalle
REIN Registry, Biomedicine Agency, La Plaine Saint Denis, France
Kidney Int 77:700-7. 2010..diabetes, cardiovascular diseases, or low body mass index and level of albuminemia; or were started with peritoneal dialysis. During a median follow-up of 21.9 months, 3945 patients died...
- Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New ZealandDavid W Johnson
Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia
Am J Kidney Dis 53:290-7. 2009The aim of the present investigation is to compare rates, types, causes, and timing of infectious death in incident peritoneal dialysis (PD) and hemodialysis (HD) patients in Australia and New Zealand.
- The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The NetherlandsKitty J Jager
Department of Medical Informatics, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Am J Kidney Dis 43:891-9. 2004..The aim of the current study is to determine the influence of different factors on long-term dialysis modality choice...
- Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal diseaseRajnish Mehrotra
Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
Arch Intern Med 171:110-8. 2011The annual payer costs for patients treated with peritoneal dialysis (PD) are lower than with hemodialysis (HD), but in 2007, only 7% of dialysis patients in the United States were treated with PD...
- Quantitative evaluation and assessment of peritoneal morphologic changes in peritoneal dialysis patientsTetsutaro Shimaoka
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine, Tokyo, Japan
Nephrol Dial Transplant 25:3379-85. 2010Morphologic changes of the peritoneum such as peritoneal fibrosis and vasculopathy develop during peritoneal dialysis (PD). In 2002, Williams et al. reported microscopic characteristics of peritoneal changes in PD patients...
- An update on peritoneal dialysis solutionsElvia Garcia-Lopez
Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, K56 Karolinska University Hospital Huddinge, S 141 86 Stockholm, Sweden
Nat Rev Nephrol 8:224-33. 2012b>Peritoneal dialysis (PD) has achieved its current position as the most commonly used home-based dialysis therapy--and with patient survival equal to that seen with hemodialysis--despite the use of glucose-based dialysis solutions with ..
- Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patientsJoanna R Ghali
Australia and New Zealand Dialysis and Transplant Registry and Department of Nephrology, Royal Adelaide Hospital, Adelaide, Australia
Perit Dial Int 31:651-62. 2011..December 2008 with the aim of describing the nature of peritonitis, therapies, and outcomes in patients on peritoneal dialysis (PD) in Australia. At least 1 episode of PD was observed in 6639 patients...
- Rate of decline of residual renal function is associated with all-cause mortality and technique failure in patients on long-term peritoneal dialysisChia Te Liao
Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
Nephrol Dial Transplant 24:2909-14. 2009Residual renal function (RRF) at the initiation of peritoneal dialysis (PD) therapy can predict patient outcome. However, RRF declines with time at variable rates in different patients...
- A quarter of a century of adult peritoneal dialysis-related peritonitis at an Australian medical centerFiona Brown
Department of Nephrology, Monash Medical Centre, Clayton, Victoria, Australia
Perit Dial Int 27:565-74. 2007Peritonitis remains one of the major complications of peritoneal dialysis (PD) and results in reduced technique survival and increased patient morbidity and mortality.
- Pathophysiological changes to the peritoneal membrane during PD-related peritonitis: the role of mesothelial cellsSusan Yung
Department of Medicine, University of Hong Kong, Queen Mary Hospital, Pokfulam, Hong Kong
Mediators Inflamm 2012:484167. 2012The success of peritoneal dialysis (PD) is dependent on the structural and functional integrity of the peritoneal membrane...
- Encapsulating peritoneal sclerosis: clinical significance and implicationsT Augustine
Manchester Institute of Nephrology and Transplantation, Manchester Royal Infirmary, Manchester, UK
Nephron Clin Pract 111:c149-54; discussion c154. 2009Encapsulating peritoneal sclerosis (EPS) is a rare but serious complication of peritoneal dialysis (PD)...
- Linkage of some trace elements, peripheral blood lymphocytes, inflammation, and oxidative stress in patients undergoing either hemodialysis or peritoneal dialysisChih Hung Guo
Institute of Biomedical Nutrition, Hung Kuang University, Taichung, Taiwan, Republic of China
Perit Dial Int 31:583-91. 2011..trace elements may affect the inflammatory and immunological state of patients on hemodialysis (HD) or peritoneal dialysis (PD)...
- Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS StudyMario R Korte
Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands
Nephrol Dial Transplant 26:691-7. 2011Encapsulating peritoneal sclerosis (EPS) is a serious complication of peritoneal dialysis (PD) with an increasing incidence...
- Encapsulating peritoneal sclerosis: incidence, predictors, and outcomesDavid W Johnson
Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia
Kidney Int 77:904-12. 2010Encapsulating peritoneal sclerosis is a complication of peritoneal dialysis characterized by persistent, intermittent, or recurrent adhesive bowel obstruction...
- Nutrition in patients on peritoneal dialysisSeung Hyeok Han
Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei ro Seodaemun gu, Seoul 120 752, Korea
Nat Rev Nephrol 8:163-75. 2012..The causes and clinical features of PEW in patients on peritoneal dialysis and hemodialysis are comparable; assessment of the factors that lead to PEW in patients receiving ..
- Hemoglobin variability in patients with chronic kidney disease in the NetherlandsKarien van der Putten
Department of Internal Medicine, Meander Medical Center, Amersfoort the Netherlands
Int J Artif Organs 32:787-93. 2009..Information on hemoglobin cycling in Europe is limited. We investigated hemoglobin variability in the Netherlands. Hemodialysis and peritoneal dialysis patients were studied and pre-dialysis patients were enrolled.
- Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranesSuchai Sritippayawan
Division of Nephrology, Department of Internal Medicine, Medical Molecular Biology Unit, Office for Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand
J Proteome Res 6:4356-62. 2007Efficacy of peritoneal dialysis is determined by solute transport through peritoneal membranes...
- Effect of fluid and sodium removal on mortality in peritoneal dialysis patientsK Ates
Ankara University Medical School, Ibn i Sina Hospital, Department of Nephrology, Ankara, Turkey
Kidney Int 60:767-76. 2001Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.
- Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized studyMarianne Haag-Weber
St Elisabeth Krankenhaus, Straubing, Germany
Nephrol Dial Transplant 25:2288-96. 2010Residual renal function (RRF) impacts outcome of peritoneal dialysis (PD) patients. Some PD fluids contain glucose degradation products (GDPs) which have been shown to affect cell systems and tissues...
- Ossification of the peritoneal membraneNicola Di Paolo
Department of Nephrology and Dialysis, University Hospital, Siena, Italy
Perit Dial Int 24:471-7. 2004b>Peritoneal dialysis (PD) patients rarely develop sclerosing peritonitis (SP), a severe, life-threatening condition of unknown pathogenesis...
- Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in CanadaKaren Yeates
Department of Medicine, Queen s University, Kingston, Ontario, Canada
Nephrol Dial Transplant 27:3568-75. 2012..0% of patients on peritoneal dialysis (PD) and 48.9% on hemodialysis (HD) and a remaining 40.1% living with a functioning kidney transplant...
- Body size and outcomes on peritoneal dialysis in the United StatesJon J Snyder
Nephrology Analytical Services, Minneapolis Medical Research Foundation, Minneapolis, Minnesota 55404, USA
Kidney Int 64:1838-44. 2003Being overweight is often cited as a relative contraindication to peritoneal dialysis. Our primary objective was to determine whether actual mortality rates support this opinion.
- Peritoneal dialysis-associated peritonitis in Scotland (1999-2002)David Kavanagh
The Scottish Renal Registry, Royal Infirmary, Castle Street, Glasgow G4 0SF, UK
Nephrol Dial Transplant 19:2584-91. 2004Peritonitis is a major complication of peritoneal dialysis (PD). We have performed a national study of all patients on PD in Scotland over a 3...
- Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centreSung Hee Chung
Hyonam Kidney Laboratory, Soon Chun Hyang University, 657 Hannam Dong, Yongsan Ku, Seoul 140 743, Korea
Nephrol Dial Transplant 20:1207-13. 2005Dialysis patient mortality remains high, and this high mortality may be due to many factors. In peritoneal dialysis (PD) patients, old age, co-morbid diseases, malnutrition, low residual renal function (RRF) and a high peritoneal ..
- Initial glucose load predicts technique survival in patients on chronic peritoneal dialysisHon Yen Wu
Department of Internal Medicine, Yun Lin branch, National Taiwan University Hospital, Yun Lin, Taiwan
Am J Nephrol 28:765-71. 2008A high glucose content in peritoneal dialysis (PD) solution may result in unfavorable changes on peritoneal character and worsened metabolic profiles...
- Cardiovascular problems in dialysis patients: impact on survivalManavjot S Sidhu
Department of Internal Medicine, University of Missouri, Columbia, Missouri 65212, USA
Adv Perit Dial 26:47-52. 2010..from clinical trials, data from randomized controlled trials regarding outcomes in patients undergoing peritoneal dialysis are almost absent...
- Inflammatory cytokines, angiogenesis, and fibrosis in the rat peritoneumPeter J Margetts
Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada
Am J Pathol 160:2285-94. 2002Peritonitis, a common complication of peritoneal dialysis, is followed by acute changes in the function of the peritoneum. The role of inflammatory cytokines in these processes is not clearly identified...
- Higher rate and earlier peritonitis in Aboriginal patients compared to non-Aboriginal patients with end-stage renal failure maintained on peritoneal dialysis in Australia: analysis of ANZDATAWai H Lim
Renal Unit, Queen Elizabeth Hospital, Adelaide, South Australia, Australia
Nephrology (Carlton) 10:192-7. 2005Aboriginal patients maintained on peritoneal dialysis (PD) have a higher rate of technique failure than any other racial group in Australia...
- Cancer in patients on chronic dialysis in KoreaJung Eun Lee
Division of Nephrology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
J Korean Med Sci 24:S95-S101. 2009..3%) out of 4,562 end-stage renal disease (ESRD) patients maintained on hemodialysis (HD) or peritoneal dialysis (PD) at Yonsei University Health System from 1996 to 2005...
- Peritoneal mast cells in peritoneal dialysis patients, particularly in encapsulating peritoneal sclerosis patientsDominik M Alscher
Department of Internal Medicine, Division of General Internal Medicine and Nephrology, Robert Bosch Hospital, Stuttgart, Germany
Am J Kidney Dis 49:452-61. 2007..that increased mast cell numbers contribute substantially to the fibrosis often seen in the peritoneum of peritoneal dialysis (PD) patients, particularly those with encapsulating peritoneal fibrosis (EPS)...
- Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosisHideki Yokoi
Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Kyoto, Japan
Kidney Int 81:160-9. 2012Long-term peritoneal dialysis induces peritoneal fibrosis with submesothelial fibrotic tissue. Although angiogenesis and inflammatory mediators are involved in peritoneal fibrosis, precise molecular mechanisms are undefined...
- Vascular endothelial growth factor production and regulation in human peritoneal mesothelial cellsSonja Mandl-Weber
Nephrologisches Zentrum, Medizinische Klinik und Poliklinik Innenstadt, Klinikum der Universitat Munchen, Munich, Germany
Kidney Int 61:570-8. 2002Vascular endothelial growth factor (VEGF) was recently found in peritoneal effluents of peritoneal dialysis (PD) patients...
- The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutionsQiang Yao
Divisions of Baxter Novum and Renal Medicine, Department of Clinical Science, Karolinska Institutet, Stockholm, Sweden
Nephron Exp Nephrol 109:e71-8. 2008b>Peritoneal dialysis (PD) solutions contribute to peritoneal membrane damage...
- Peritoneal changes after exposure to sterile solutions by catheterMichael F Flessner
Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216 4505, USA
J Am Soc Nephrol 18:2294-302. 2007..These findings confirm the hypothesis that the presence of a PC catheter increases inflammatory response to sterile solutions as evidenced by the structural and functional changes in the peritoneal barrier...
- Severe vitamin D deficiency in chronic renal failure patients on peritoneal dialysisH Taskapan
Inonu University Medical School, Department of Medicine, Division of Nephrology, Malatya, Turkey
Clin Nephrol 66:247-55. 2006The aim of this study was to evaluate the prevalence of vitamin D deficiency in chronic renal failure (CRF) patients on peritoneal dialysis (PD) and to correlate the findings with various demographic and renal osteodystrophy markers.
- Cost comparison of peritoneal dialysis versus hemodialysis in end-stage renal diseaseAriel Berger
Policy Analysis, Inc, Four Davis Ct, Brookline, MA 02445, USA
Am J Manag Care 15:509-18. 2009To compare healthcare utilization and costs in patients with end-stage renal disease (ESRD) beginning peritoneal dialysis (PD) or hemodialysis (HD).
- The effects of renin-angiotensin system inhibition on regression of encapsulating peritoneal sclerosisDevrim Bozkurt
Department of Nephrology, Ege University, Izmir, Turkey
Perit Dial Int 28:S38-42. 2008..b>Peritoneal dialysis (PD) patients rarely develop EPS, a severe life-threatening condition of unknown pathogenesis...
- Mesothelial cellsSusan Yung
Department of Medicine, University of Hong Kong, Hong Kong SAR, PR China
Perit Dial Int 27:S110-5. 2007The introduction of peritoneal dialysis (PD) as a modality of renal replacement therapy has provoked much interest in the biology of the peritoneal mesothelial cell...
- Impact of ACE inhibitors and AII receptor blockers on peritoneal membrane transport characteristics in long-term peritoneal dialysis patientsInna Kolesnyk
Division of Nephrology, Academic Medical Center, Amsterdam, The Netherlands
Perit Dial Int 27:446-53. 2007Long-term peritoneal dialysis (PD) may lead to peritoneal fibrosis and ultrafiltration failure. The latter occurs due to high solute transport rates and diabetiform peritoneal sclerosis...
- Sodium removal in patients undergoing CAPD and automated peritoneal dialysisAna Rodriguez-Carmona
Division of Nephrology, Hospital Juan Canalejo, A Coruna, Spain
Perit Dial Int 22:705-13. 2002To compare sodium removal in continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dialysis (APD) patients, and to identify the main factors that modify Na removal in clinical practice in these patients.
- Increases in serum leptin levels during peritoneal dialysis are associated with inflammation and a decrease in lean body massP Stenvinkel
Division of Renal Medicine, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
J Am Soc Nephrol 11:1303-9. 2000..elevated leptin levels have been documented in uremic patients, especially in those who are treated by peritoneal dialysis (PD)...
- Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysisJ Ni
Division of Nephrology and Department of Pathology, UCL Medical School, Brussels, Belgium
Kidney Int 69:1518-25. 2006..of the implication of AQP1 in solute-free water transport, sodium sieving, and ultrafiltration (UF) during peritoneal dialysis (PD) is lacking, and the effects of its deletion on the structure of the membrane are unknown...
- Serum matrix metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 levelsGloria A Preston
Division of Nephrology and Hypertension, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Nephron 92:817-23. 2002Patients on chronic hemodialysis or peritoneal dialysis often develop an inflammatory state that causes morbidity and mortality...
- Impact of uremia, diabetes, and peritoneal dialysis itself on the pathogenesis of peritoneal sclerosis: a quantitative study of peritoneal membrane morphologyKazuho Honda
Department of Pathology, Tokyo Women s Medical University, 8 1 Kawada cho, Shinjuku ku, Tokyo 162 8666, Japan
Clin J Am Soc Nephrol 3:720-8. 2008Peritoneal interstitial fibrosis and hyalinizing vasculopathy were induced by peritoneal dialysis and other associated conditions (e.g., uremia)...
- The timing of specialist evaluation in chronic kidney disease and mortalityKraig S Kinchen
Robert Wood Johnson Clinical Scholars Program and Welch Center for Prevention, Epidemiology, and Clinical Research, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205 2223, USA
Ann Intern Med 137:479-86. 2002..Care for chronic renal failure involves management of complications and preparation for possible dialysis. Patients often are not evaluated by nephrologists in a timely manner...
- Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized studyConstantijn J A M Konings
Department of Internal Medicine, University Hospital Maastricht, The Netherlands
Kidney Int 63:1556-63. 2003Overhydration is a risk factor for hypertension and left ventricular hypertrophy in peritoneal dialysis patients. Recently, a high prevalence of subclinical overhydration was observed in peritoneal dialysis patients...
- Epidemiology of encapsulating peritoneal sclerosis in JapanHideki Kawanishi
Akane Foundation, Tsuchiya General Hospital, Hiroshima, Japan
Perit Dial Int 25:S14-8. 2005Since the first peritoneal dialysis (PD) patients with encapsulating peritoneal sclerosis (EPS) were reported in 1980, EPS has been considered primarily a fatal complication...
- Glycemic control and survival in peritoneal dialysis patients with diabetes mellitusUyen Duong
Harold Simmons Center for Chronic Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, California 90509 2910, USA
Clin J Am Soc Nephrol 6:1041-8. 2011The optimal target for glycemic control has not been established for diabetic peritoneal dialysis (PD) patients.
- Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysisEdward A Ross
Division of Nephrology, Hypertension, and Transplantation, University of Florida, Gainesville, FL 32610 0224, USA
Am J Nephrol 28:97-106. 2008..This study investigates the effects of oral paricalcitol to reduce PTH in patients receiving chronic HD and peritoneal dialysis (PD).
- Computed tomographic findings characteristic for encapsulating peritoneal sclerosis: a case-control studyAnniek Vlijm
Department of Medicine, University of Amsterdam, Amsterdam, The Netherlands
Perit Dial Int 29:517-22. 2009..To establish CT findings characteristic for EPS, we compared CT findings between EPS patients and long-term peritoneal dialysis (PD) patients without EPS.
- NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patientsRamon Paniagua
Unidad de Investigacion Medica en Enfermedades Nefrologicas, Hospital de Especialidades, CMN Siglo XXI, Mexico City
Nephrol Dial Transplant 25:551-7. 2010..It has been suggested that continuous ambulatory peritoneal dialysis (CAPD), automated peritoneal dialysis (APD) and haemodialysis (HD) may have different effects on fluid ..
- The progression and impact of vascular calcification in peritoneal dialysis patientsAdriano Luiz Ammirati
Nephrology Division, Federal University of Sao Paulo, 282 Pedro de Toledo Street, São Paulo 04039 000, Brazil
Perit Dial Int 27:340-6. 2007..Little information is available regarding peritoneal patients...
- Cardiovascular risk in the peritoneal dialysis patientRaymond T Krediet
Division of Nephrology, Department of Medicine, Academic Medical Centre University of Amsterdam, P O Box 22700, 1100 DE Amsterdam, The Netherlands
Nat Rev Nephrol 6:451-60. 2010Cardiovascular death is the most frequent cause of death in patients on peritoneal dialysis. Risk factors for cardiovascular death in these patients include those that affect the general population as well as those related to end-stage ..
- Survival advantages of obesity in dialysis patientsKamyar Kalantar-Zadeh
Division of Nephrology and Hypertension, Los Angeles Biomedical Institute at Harbor UCLA Medical Center, Torrance, CA 90509 2910, USA
Am J Clin Nutr 81:543-54. 2005..or dialysis-risk-paradox is relatively consistent in MHD patients, studies in CKD patients undergoing peritoneal dialysis have yielded mixed results...
- Continuous peritoneal dialysis-associated peritonitis: a review and current conceptsLaura Troidle
New Haven CAPD, Renal Research Institute, New Haven, Connecticut, USA
Semin Dial 16:428-37. 2003The percentage of end-stage renal disease (ESRD) patients in the United States maintained on continuous peritoneal dialysis (CPD) therapy is decreasing...
- The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membraneJohn D Williams
Institute of Nephrology, University Hospital of Wales College of Medicine, Heath Park, Cardiff, Wales, UK
Kidney Int 66:408-18. 2004Although peritoneal dialysis (PD) is a widely accepted form of renal replacement therapy (RRT), concerns remain regarding the bioincompatible nature of standard PD fluid...
- 2005 Annual Report: ESRD Clinical Performance Measures ProjectRaynel Kinney
Am J Kidney Dis 48:S1-106. 2006
- Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA studyJ M Bargman
Division of Nephrology, Toronto General Hospital, University of Toronto, 200 Elizabeth Street EN10 216, Toronto, Ontario M5G 2C4, Canada
J Am Soc Nephrol 12:2158-62. 2001Studies of the adequacy of peritoneal dialysis and recommendations have assumed that renal and peritoneal clearances are comparable and therefore additive. The CANUSA data were reanalyzed in an effort to address this assumption...
- Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysisK Scott Brimble
25 Charlton Avenue East, Hamilton, ON, Canada, L8N 1Y2
J Am Soc Nephrol 17:2591-8. 2006Peritoneal membrane solute transport in peritoneal dialysis (PD) patients is assessed by the peritoneal equilibration test, which measures the ratio of creatinine in the dialysate to plasma after a standardized 4-h dwell (D/Pc)...
- Peritoneal dialysis in the 21st century: an analysis of current problems and future developmentsRam Gokal
Department of Renal Medicine, Manchester Royal Infirmary, Manchester, United Kingdom
J Am Soc Nephrol 13:S104-16. 2002
- Changes in quality of life during hemodialysis and peritoneal dialysis treatment: generic and disease specific measuresAlbert W Wu
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
J Am Soc Nephrol 15:743-53. 2004..20 yr of use, relative differences in health-related quality of life (HRQOL) between hemodialysis (HD) and peritoneal dialysis (PD) are not clearly known...
- Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysisS J Davies
Department of Nephrology, North Staffordshire Hospitals Trust, Stoke on Trent, United Kingdom
J Am Soc Nephrol 12:1046-51. 2001Peritoneal solute transport increases with time on treatment in a proportion of peritoneal dialysis (PD) patients, contributing to ultrafiltration failure...
- An all titanium transcutaneous access device (TAD) for peritoneal dialysisRobert Whalen; Fiscal Year: 2007unreadable] DESCRIPTION (provided by applicant): Chronic transcutaneous access is needed for peritoneal dialysis (PD) and new emerging medical therapies...
- Conservative Versus Dialytic Management in Stage V Chronic Kidney DiseaseGLENN MATTHEW CHERTOW; Fiscal Year: 2010..73m2. The dialytic intervention will include initiation of thrice weekly hemodialysis or conventional peritoneal dialysis following randomization...
- Comparative Effectiveness of Dialysis ModalitiesRajnish Mehrotra; Fiscal Year: 2013..The comparisons of these therapies with peritoneal dialysis and/or thrice-weekly conventional hemodialysis will be adequately powered for all-cause mortality, the ..
- Acute Renal Failure Mediated Lung InjurySarah Faubel; Fiscal Year: 2013..if the uremic factors that stimulate IL-6 production in AKI may be removed by dialysis, the effect of acute peritoneal dialysis on IL-6 production and serum IL-6 will be determined...
- Associations among RAAS Inhibitors, Residual Kidney Function, and CV Events in PDJenny I Shen; Fiscal Year: 2013..However, data on their effectiveness in patients undergoing peritoneal dialysis (PD) are limited...
- Regenerative Integration of Percutaneous ImplantsPHIL GORDON CAMPBELL; Fiscal Year: 2013DESCRIPTION (provided by applicant): Percutaneous medical devices such as central venous catheters, peritoneal dialysis catheters, and intraosseointegrated implants are ubiquitous in modern healthcare despite the fact that there is a ..
- Experience of Managing ESRD Dietary ModicationsMAYA NICOLE CLARK; Fiscal Year: 2011Hemodialysis, peritoneal dialysis, and kidney transplant are the only treatment options available for patients with end-stage renal disease (ESRD)...
- Anti-Infective Dermal Integration Sleeves for Needle Free Dialysis Access DevicesAndrew Marshall; Fiscal Year: 2013..Less expensive and more patient-friendly alternatives of home peritoneal dialysis (PD) and home hemodialysis (HHD) have not seen wide adoption, in part due to exit site infection risk (in ..
- Understanding Sources of Bias and Outcomes in Peritoneal Dialysis Patient ResearcKamyar Kalantar Zadeh; Fiscal Year: 2010..by applicant): The proportion of individuals with advanced chronic kidney disease who undergo chronic peritoneal dialysis (CPD) treatment, currently <8% of the 400,000 dialysis patients in the USA, has been declining steadily ..
- Infections in Patients treated with Dialysis: Incidence, Risk Factors and OutcomeSeth Wright; Fiscal Year: 2013..understanding of the patterns and risks of infection in patients treated with maintenance hemodialysis and peritoneal dialysis. Infections are a major cause of mortality, morbidity, and health care utilization in the growing dialysis ..
- Unraveling the ultrafiltration rate--mortality association in dialysis patientsJennifer E Flythe; Fiscal Year: 2012..Other untested methods of IDWG control including interdialytic peritoneal dialysis and wearable ultrafiltration devices do exist...
- The Production of Uremic Solutes by Colon MicrobesTimothy W Meyer; Fiscal Year: 2010..investigators have identified large differences in indican and p-cresol sulfate production in patients on peritoneal dialysis and patients on hemodialysis...
- Cascading Impacts of Bundled Payment on Peritoneal Dialysis Provision &OutcomesVirginia Wang; Fiscal Year: 2013DESCRIPTION (provided by applicant): Despite the appeal of peritoneal dialysis (PD) to patients, physicians, and providers, there is limited understanding of the mechanisms behind PD's low and diminishing utilization in the US...
- COATING OF URINARY PROTHESES TO PREVENT ENCRUSTATIONHarmeet Sidhu; Fiscal Year: 2000..catheters are frequently used in urological and nephrological medicine for the management of urinary and peritoneal dialysis flow, haemodialysis, and drainage of renal calculi following laser or lithotripsy treatment...
- 14th International Conference on Dialysis Advances in CKD 2012Mary Carter; Fiscal Year: 2012..Nephrology (ISN), the International Pediatric Nephrology Association (IPNA), the International Society of Peritoneal Dialysis (ISPD), the National Kidney Foundation (NKF) the Sustainable Kidney Care Foundation (SKCF) and the Renal ..
- Dynamics of Peritoneal Dialysis Associated PeritonitisJohn Hotchkiss; Fiscal Year: 2004..on interactions between dynamics of bacterial growth and optimal bacterial clearance in the setting of peritoneal dialysis associated peritonitis (PDAP)...
- Stent Lock Mechanism for Transcutaneous CathetersNICHOLAS VITALE; Fiscal Year: 2005b>Peritoneal dialysis, intravascular access for chemotherapy, transcutaneous intrathoracic access of cardiac power lines, and suprapubic bladder drainage are among the clinical applications where transcutaneous catheters are routinely used ..
- IN VIVO STUDY OF INTERSTITIAL CONVECTIONMICHAEL FLESSNER; Fiscal Year: 1999..homeostasis but also of major importance in therapeutic procedures such as macromolecular drug delivery or peritoneal dialysis. Recently proposed mathematical models of interstitial fluid and protein transport include theories of ..
- ADHERENCE AND ADJUSTMENT IN END-STAGE RENAL DISEASEAlan Christensen; Fiscal Year: 2003..g., continuous ambulatory peritoneal dialysis) but poorer adherence when receiving staff administered dialysis (e.g., center hemodialysis)...
- Assessing Functional Outcomes in Adolescent with ESRDSusan Furth; Fiscal Year: 2002..quality of life (HRQL) for pediatric patients with chronic renal failure or ESRD treated with hemodialysis, peritoneal dialysis or transplant. Resources provided by the RO3 award will allow Dr...
- Commercialization of Human Omental Mesothelial Cells for ResearchYOLANDA LEA CURRIE; Fiscal Year: 2007..DESCRIPTION (provided by applicant): Mesothelial cells have been found to be pivotal in tumor metastasis, peritoneal dialysis, and inflammatory response...
- S.T.R.A.P Sonos Transportable Renal Application ProductMartin Roberts; Fiscal Year: 2005..5 billion. Hemodialysis requires patient treatment 3 times a week for 3-4 hours. Peritoneal dialysis is an option utilized by less than 10% of patients requiring manual exchange of 2 liters of dialysate every ..
- Commercialization of Human Mesothelial Cells for ResearchYOLANDA RENEE LEA CURRIE; Fiscal Year: 2010Mesothelial cells have been found to be pivotal in tumor metastasis, peritoneal dialysis, and inflammatory response...
- DIURNAL AND PULSATILE PTH SECRETION IN RENAL FAILUREWilliam Goodman; Fiscal Year: 2001..with secondary hyperparathyroidism will also be evaluated, and the respective roles of hemodialysis and peritoneal dialysis as separate modifiers of diurnal and pulsatile PTH secretion in end-stage renal disease will be examined...
- Comorbidity, Costs and Outcomes in Dialysis PatientsSrinivasan Beddhu; Fiscal Year: 2002..Prior studies showed patients with high comorbidity have higher peritoneal dialysis technique failure...
- PRODUCTION OF STERILE WATER FOR INJECTION ON DEMANDEdit Hegyi; Fiscal Year: 2001..of sterile online mixing technology it will provide sterile replacement fluids and sterile dialyzate for peritoneal dialysis and continuous renal replacement therapy...
- Dietary Adherence Enhancement in Peritoneal DialysisMARY SEVICK; Fiscal Year: 2007..study will pilot test an intervention! based on self-efficacy theory, to improve adherence to the peritoneal dialysis dietary regimen...
- Patient-Oriented Research in Kidney DiseaseNeil Powe; Fiscal Year: 2009..This is a national prospective cohort study comparing treatment and outcomes in hemodialysis and peritoneal dialysis patients...
- LONG-TERM PERCUTANEOUS ACCESS DEVICE FOR HOME THERAPIESPaul Freed; Fiscal Year: 1999..that require long- term body access, such as total parenteral nutrition, drug delivery, ambulatory peritoneal dialysis, and heart assist devices...
- LONG-TERM PERCUTANEOUS ACCESS DEVICE FOR HOME THERAPIESLUDMILA BERNSTAM; Fiscal Year: 2005..devices for treatment of chronic heart failure, total parenteral nutrition, drug delivery, and ambulatory peritoneal dialysis. The PAD is pre-seeded with autologous fibroblasts derived from a small sample of the recipient's skin...
- PATIENT ADHERENCE AND ADJUSTMENT IN RENAL DIALYSISAlan Christensen; Fiscal Year: 1999..e., continuous ambulatory peritoneal dialysis-- CAPD) but poorer adherence when receiving staff-administered dialysis (i.e., center hemodialysis)...
- Colorimetric Breathalyzer for Dialysis MonitoringWILLIAM MCNAMARA; Fiscal Year: 2002..of great value in determining the dialysis state of both patients undergoing hemodialysis in a clinic and peritoneal dialysis at home. ChemSensing, Inc...
- GENETIC SUSCEPTIBILITY TO END STAGE RENAL DISEASESudha Iyengar; Fiscal Year: 2002..for ESRD (but concordant for Type 2 diabetes mellitus) and 200 additional family members from hemodialysis, peritoneal dialysis and transplant centers as part of a study to identify genetic risk factors for ESRD...
- CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD)Dimitrios Oreopoulos; Fiscal Year: 1980A new type of dialytic therapy - Continuous Ambulatory Peritoneal Dialysis (CAPD) - originally pioneered by NIH supported research in the United States has recently been significantly improved by Dr...
- SURFACE MODIFICATION FOR IMPROVED PERCUTANEOUS CATHETERSDAVID CLAPPER; Fiscal Year: 1991This project is designed to improve continuous ambulatory peritoneal dialysis (CAPD) catheters by developing an improved exit port that will produce a stable integument seal and greatly reduce the frequency of catheter sepsis...
- ON LINE PRODUCTION OF ULTRAPURE WATER FOR DIALYSISPeter Grandics; Fiscal Year: 1999..This technology has broader range of applications that we have outlined, including peritoneal dialysis, home hemodialysis, production of WFI grade solutions in hospitals, pharmacies, and pharmaceutical ..
- MMHD CLINICAL CENTERMichael Rocco; Fiscal Year: 2001..The staff at these dialysis centers have participated in both hemodialysis and peritoneal dialysis clinical research protocols...
- PROCESS, OUTCOME AND QUALITY OF CARE IN ESRDNeil Powe; Fiscal Year: 2004..The purpose of the project now shifts from comparing outcomes between hemodialysis and peritoneal dialysis patients (the aim of the original project) to studying of the relation between a variety of process ..
- Improved Catheter System for DialysisVinayak Kini; Fiscal Year: 2003One aim of this project is to develop a protocol to optimize the design of peritoneal dialysis catheter systems for use in the treatment of end-stage renal disease...
- Effects of Hyaluronan on Interstitial ConvectionMICHAEL FLESSNER; Fiscal Year: 2007..to quantify solute diffusion and convection in the subperitoneal muscle of anesthetized rats during peritoneal dialysis. The in vivo model permits control of the tissue pressure forces and measurement of the pressure profile ..
- PERITONEAL DELIVERY OF ANTINEOPLASTIC MACROMOLECULESMICHAEL FLESSNER; Fiscal Year: 2004..of the MAb to tumor, a human xenograft will be transplanted into the abdominal wall of athymic rats, and peritoneal dialysis will be used to deliver MAb. The tumor position permits control of the intraperitoneal (i.p...
- Functional Health CAT in Chronic Kidney DiseaseJOHN WARE; Fiscal Year: 2002..Disease instruments will be calibrated on a common metric for each HRQOL domain to specifically address peritoneal dialysis. CKD-CAT will be evaluated (reliability, validity and precision) to create a fully operational system that ..
- ENZYME IMMOBILIZATION FOR REMOVAL OF TOXIC METABOLITESPATRICK GUIRE; Fiscal Year: 1991..such as diet manipulation, gene replacement therapy, chemotherapy, transfusions, transplantations, and peritoneal dialysis have produced marginal improvements in these patients...
- Antimicrobial Dendrimers for Catheter UtilizationHANS GLAESER; Fiscal Year: 2001..Phase I focus will be on central venous catheters with peritoneal dialysis catheters being evaluated at a later time...
- Poloxamer-188 for the prevention of fibrosis during peritoneal dialysisBRUCE MARKHAM; Fiscal Year: 2008..unreadable] [unreadable] This application is focused on preventing adverse events associated with chronic peritoneal dialysis (PD), a renal replacement therapy for end stage renal disease (ESRD)...
- MethLock vs. heparin as dialysis catheter lockStephen Ash; Fiscal Year: 2008..In Phase II we will implement the protocol in a number of dialysis centers and complete the study as originally proposed or as modified after Phase I. ..
- Pheresis Treatment of Bioterrorism-Induced SepsisStephen Ash; Fiscal Year: 2005..The safety systems of the existing PF system will be modified to meet the needs of the stand-alone system. Finally, an animal model of sepsis will be used to check efficacy and safety of the entire system. ..
- Nutritional/Inflammatory Evaluation of Dialysis PatientsKamyar Kalantar Zadeh; Fiscal Year: 2005....
- Anti-Inflammatory and Anti-Oxidative Nutrition in Dialysis PatientsKamyar Kalantar Zadeh; Fiscal Year: 2008..unreadable] [unreadable] [unreadable]..
- ROLE OF PARATHYROID HORMONE IN RENAL OSTEODYSTROPHYIsidro B Salusky; Fiscal Year: 2009..The results of the study should provide new information on the relationship between PTH and bone formation in CKD and they are likely to have important implications for the diagnosis and treatment of renal osteodystrophy. ..
- Cardiovascular Disease and Diabetic NephropathyRajnish Mehrotra; Fiscal Year: 2008..The applicant has institutional support and a career development plan including obtaining a Masters in Clinical Investigation, to achieve his career goals. ..